Viewing Study NCT06855160


Ignite Creation Date: 2025-12-25 @ 2:09 AM
Ignite Modification Date: 2026-01-07 @ 4:13 AM
Study NCT ID: NCT06855160
Status: RECRUITING
Last Update Posted: 2025-12-04
First Post: 2025-02-25
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study on the Immune Response and Safety of an Investigational Chickenpox Vaccine and a Marketed Measles, Mumps and Rubella Vaccine When Administered as Intramuscular Injection to Healthy Children 12 to 15 Months of Age
Sponsor: GlaxoSmithKline
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module